{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidkxufdjjkqzou2ioz2pgklhhlmdo3hkt3ocvsbpxkdnwjrv2li7e",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mob2n2wnbjx2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibak3trdqbkq73apd35rrmnrlz6h7nnnouhbn66y3ykk3vhlwijoq"
    },
    "mimeType": "image/jpeg",
    "size": 1111979
  },
  "path": "/news/2026-06-hormone-medication-menopausal-symptoms-women.html",
  "publishedAt": "2026-06-14T10:00:04.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "The first real-world study of the FDA-approved nonhormone treatment fezolinetant found the menopausal medication improved hot flashes, depression and anxiety in women, according to industry-sponsored research presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.",
  "title": "Non-hormone medication addresses menopausal symptoms in women"
}